Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I haven’t seen that. I saw 800 million A/S, 180 outstanding
I alerted TKCI and JFIL in February. Take a look at PTLF. That L2 on the ask is amazing.
You liked my TKCI call last week. Check out PTLF. That L2 is ripe for a 10 bagger. Hardly anything on the ask
PTLFbids coming up again. All you need to do is look at this L2 on the ask.Easy 10 bagger with volume.
NITE 0.02 22,000 09:30
VNDM 0.05 10,000 05/31
CSTI 0.115 5,000 08:30
CDEL 0.175 9,500 09:36
CANT 0.262 2,500 08:30
CFGN 0.51 1,000 04/03
PTLF bids coming up again. All you need to do is look at this L2 on the ask.E asy 10 bagger with volume.
NITE 0.02 22,000 09:30
VNDM 0.05 10,000 05/31
CSTI 0.115 5,000 08:30
CDEL 0.175 9,500 09:36
CANT 0.262 2,500 08:30
CFGN 0.51 1,000 04/03
I came across this yesterday and it looks phenomenal. Been trying to alert it on some other boards today. That L2 is a thing of beauty. Any demand and this will take off
PTLF .0075x.02 but look at the l2. That is insane
NITE 0.02 22,000 09:30
VNDM 0.05 10,000 05/31
CSTI 0.115 5,000 08:30
CDEL 0.175 9,500 09:36
CANT 0.262 2,500 08:30
CFGN 0.51 1,000 04/03
PTLF .0075x.02 but look at the l2. That is insane
NITE 0.02 22,000 09:30
VNDM 0.05 10,000 05/31
CSTI 0.115 5,000 08:30
CDEL 0.175 9,500 09:36
CANT 0.262 2,500 08:30
CFGN 0.51 1,000 04/03
PTLF .01x.02 here come the bids. This is thin to .26 ladies and gentlemen
PTLF .01x.02 here come the bids. This is thin to .26 ladies and gentlemen
.01x.02 ready to fly
Sounds like the pumpers have left. This hit my sell target so I’m out. GLTY Law. I’m on to PTLF .01. Very thin to .26
PTLF .01s cleared yesterday. .02’s up. Very thin to .11
PTLF .01s cleared yesterday. .02’s up. Very thin to .11
PTLF .01, this puppy is very thin to .05. No one listened to my TKCI and JFIL calls for months.
PTLF .01, this puppy is very thin to .05. No one listened to my TKCI and JFIL calls for months.
Volume pouring in today. I opened a small position
PTLF .0105 very thin to .05. Volume pouring in. Bids are rising and stacking
PTLF .0105 very thin to .05. Volume pouring in. Bids are raising and stacking
PTLF volume coming in today. Could see a move higher pretty quick.
PTLF alert. If you missed my TKCI and JFIL alerts, don’t miss this one.
PTLF alert. If you missed my TKCI and JFIL alerts, don’t miss this one.
PTLF alert. If you missed my TKCI and JFIL alerts, don’t miss this one.
I’ve opened a position here. Looks like we’ve been treading in this range for a while
They are hiding bids. I’ve been above the bid for a week at least
TBG holdings sends me emails. I’m on their list
TKCI holding company just released this
MediXall Group, Inc. Launches New Flexible Patient Financing Solution
(Fort Lauderdale, FL, May 30, 2018) -- MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, announced today the launch of MediXall Finance Group, a new flexible patient financing program to address traditional deductibles and high out-of-pocket expenses that patients face today, including those for services in elective markets, such as dentists, audiologists and surgeons in cosmetic, eye, orthopedic and other specialties.
Designed in partnership with Modern Asset Management, MediXall Finance works with healthcare providers to offer patients affordable, consumer-friendly financing solutions to all patients who struggle with their medical expenses. Beyond the benefit of supplying patients with a viable payment option for their healthcare needs, MediXall Finance also brings providers meaningful benefits. Providers will not have to expend valuable resources on billing, processing or collecting from patients utilizing the Company’s solution, and importantly, they will be able to focus on what matters most: growing their business while delivering high-quality, low-cost care. To assist patients across the credit spectrum, including patients with more challenging credit profiles, MediXall Finance purchases the accounts receivable of patients it deems most likely to repay, based on its proprietary risk-scoring algorithm, at a discount to their stated balance. MediXall Finance has capital committed to fund the launch of this new flexible patient financing program.
“Through our patient financing platform, we are extending our company’s mission to empower our network of providers with unprecedented cash flow flexibility and control, as well as bolstering their ability to offer patients greater options to manage their own healthcare. The existing patient finance solutions in the market are mostly focused on patients with prime credit scores, but MediXall Finance extends these offerings all the way across the credit spectrum from prime to subprime.” said Michael Swartz, President of MediXall.
With the ongoing shift in financial responsibility, many patients are left untreated or with an unplanned financial burden. According to a recent industry report, consumers’ out-of-pocket healthcare costs have risen from $250 per year in 1980 to $1,813 in the fourth-quarter of 2017. Compared to a year earlier average out-of-pocket healthcare costs increased 11% during 2017. Additionally, out-of-pocket spending is expected to reach $608 billion in 2019. Healthcare providers will then incur the cost of managing patient responsibility over time, which is complicated by legacy technologies built to service insurance payors as opposed to individual receivables. As a result, A/R and bad debt increase, while patient satisfaction scores plummet. Through MediXall’s consumer-friendly loan program, patients can secure payment options for their care or needed/elective treatment and healthcare providers improve the financial performance of their practice, while increasing patient satisfaction and loyalty.
“As patients bear more and more financial responsibility for their healthcare, success in managing self-pay portion of accounts is critical to a provider’s financial health, improving patient satisfaction, and maintaining compliance. We developed the MediXall Finance Solution to deliver on all three” says Steve Hodgdon, Modern Asset Management’s founder. Mr. Hodgdon brings 38 years of credit experience with two decades of success helping hospitals and other healthcare providers improve their accounts receivable performance.
MediXall Group, Inc. Launches New Flexible Patient Financing Solution
(Fort Lauderdale, FL, May 30, 2018) -- MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, announced today the launch of MediXall Finance Group, a new flexible patient financing program to address traditional deductibles and high out-of-pocket expenses that patients face today, including those for services in elective markets, such as dentists, audiologists and surgeons in cosmetic, eye, orthopedic and other specialties.
Designed in partnership with Modern Asset Management, MediXall Finance works with healthcare providers to offer patients affordable, consumer-friendly financing solutions to all patients who struggle with their medical expenses. Beyond the benefit of supplying patients with a viable payment option for their healthcare needs, MediXall Finance also brings providers meaningful benefits. Providers will not have to expend valuable resources on billing, processing or collecting from patients utilizing the Company’s solution, and importantly, they will be able to focus on what matters most: growing their business while delivering high-quality, low-cost care. To assist patients across the credit spectrum, including patients with more challenging credit profiles, MediXall Finance purchases the accounts receivable of patients it deems most likely to repay, based on its proprietary risk-scoring algorithm, at a discount to their stated balance. MediXall Finance has capital committed to fund the launch of this new flexible patient financing program.
“Through our patient financing platform, we are extending our company’s mission to empower our network of providers with unprecedented cash flow flexibility and control, as well as bolstering their ability to offer patients greater options to manage their own healthcare. The existing patient finance solutions in the market are mostly focused on patients with prime credit scores, but MediXall Finance extends these offerings all the way across the credit spectrum from prime to subprime.” said Michael Swartz, President of MediXall.
With the ongoing shift in financial responsibility, many patients are left untreated or with an unplanned financial burden. According to a recent industry report, consumers’ out-of-pocket healthcare costs have risen from $250 per year in 1980 to $1,813 in the fourth-quarter of 2017. Compared to a year earlier average out-of-pocket healthcare costs increased 11% during 2017. Additionally, out-of-pocket spending is expected to reach $608 billion in 2019. Healthcare providers will then incur the cost of managing patient responsibility over time, which is complicated by legacy technologies built to service insurance payors as opposed to individual receivables. As a result, A/R and bad debt increase, while patient satisfaction scores plummet. Through MediXall’s consumer-friendly loan program, patients can secure payment options for their care or needed/elective treatment and healthcare providers improve the financial performance of their practice, while increasing patient satisfaction and loyalty.
“As patients bear more and more financial responsibility for their healthcare, success in managing self-pay portion of accounts is critical to a provider’s financial health, improving patient satisfaction, and maintaining compliance. We developed the MediXall Finance Solution to deliver on all three” says Steve Hodgdon, Modern Asset Management’s founder. Mr. Hodgdon brings 38 years of credit experience with two decades of success helping hospitals and other healthcare providers improve their accounts receivable performance.
They are hiding my bid here. Been bidding for a week with no luck and they won’t register mine.
Thanks! Good luck to you guys. Somebody must be front loading for the release of info
This would blow up on the day my wife delivers and I have limited access
Thinner than it has been. A lot of bid support at .0182
I don’t know. I’m on their email list but it went to my spam folder lol. That’s why I didn’t get to it. It’s on the otc site I use daily. We did have 10k in volume yesterday.
TKCI low floater news out
Turnkey Capital Inc. Signs Letter of Intent to Acquire HealthSpan Medical Systems Inc.
Ft. Lauderdale, Florida, May 14, 2018 (GLOBE NEWSWIRE) – Turnkey Capital Inc. (TKCI), today announced it has signed a letter of intent to acquire HealthSpan Medical Systems, Inc., (“Healthspan”) a TBG Holdings company that had previously been operating a medical clinic specializing in IV Therapies, Medical Marijuana registrations and Hormone Replacement therapies (HRT). HealthSpan has recently moved away from the single location clinical model and shifted focus to building IV Therapy Modules for an unlimited number of practitioners to add to their existing clinics, expanding to offer further medical support services within the next few weeks. TKCI will change its name to HealthSpan Medical Systems Inc. and focus its mission, going forward, on creating innovative wellness services that physicians and healthcare practitioners can offer through their clinics to increase revenues and scope of services.
Through a Joint Venture with CityPlace Pharmacy, HealthSpan Medical Systems is building IV Therapy Treatment Modules that can be deployed in a Practitioner’s clinic space to generate revenue for both HealthSpan and the doctor. The Company will also expand the scope to include qualified HealthSpan Physician-supervised Medical Marijuana registration services, as well as personalized Hormone Replacement Therapy. HealthSpan Medical Systems will provide the specialized medical personnel, medical supplies, and equipment to allow any healthcare provider to offer these popular and high-demand treatments.
CityPlace Pharmacy is a licensed Compounding Pharmacy. Pharmaceutical compounding is the customization of legal and FDA-approved substances to conform to individual needs of a human or animal patient, and can only be performed under the direct supervision of a pharmacist licensed by a state board of pharmacy. CityPlace Pharmacy is able to produce proprietary HealthSpan IV infusion blends to target a variety of wellness needs by replenishing hydration, aiding recovery from illness or stresses, providing hangover relief, restoring vitamin & nutrient levels, refreshing cosmetic appearance and revitalizing a patient’s overall well-being.
Turnkey Capital CEO, Neil Swartz, stated, “In taking HealthSpan Medical Systems public through this intended merger, we are adding the last critical piece to the plan. HealthSpan has the management team, the joint venture agreement with CityPlace for steady product supply, and a signed agreement with MediXall Group, Inc. for sales, promotions and customer service.”
TKCI has also unwound the previously announced agreement with Palm Beach Integrative Medicine, and PBIM owner, Dr. John DeLuca, will not become Chief Medical Officer of HealthSpan.
HealthSpan Medical Systems has a waiting list of physicians who have requested IV Therapy
TKCI low floater news out
Turnkey Capital Inc. Signs Letter of Intent to Acquire HealthSpan Medical Systems Inc.
Ft. Lauderdale, Florida, May 14, 2018 (GLOBE NEWSWIRE) – Turnkey Capital Inc. (TKCI), today announced it has signed a letter of intent to acquire HealthSpan Medical Systems, Inc., (“Healthspan”) a TBG Holdings company that had previously been operating a medical clinic specializing in IV Therapies, Medical Marijuana registrations and Hormone Replacement therapies (HRT). HealthSpan has recently moved away from the single location clinical model and shifted focus to building IV Therapy Modules for an unlimited number of practitioners to add to their existing clinics, expanding to offer further medical support services within the next few weeks. TKCI will change its name to HealthSpan Medical Systems Inc. and focus its mission, going forward, on creating innovative wellness services that physicians and healthcare practitioners can offer through their clinics to increase revenues and scope of services.
Through a Joint Venture with CityPlace Pharmacy, HealthSpan Medical Systems is building IV Therapy Treatment Modules that can be deployed in a Practitioner’s clinic space to generate revenue for both HealthSpan and the doctor. The Company will also expand the scope to include qualified HealthSpan Physician-supervised Medical Marijuana registration services, as well as personalized Hormone Replacement Therapy. HealthSpan Medical Systems will provide the specialized medical personnel, medical supplies, and equipment to allow any healthcare provider to offer these popular and high-demand treatments.
CityPlace Pharmacy is a licensed Compounding Pharmacy. Pharmaceutical compounding is the customization of legal and FDA-approved substances to conform to individual needs of a human or animal patient, and can only be performed under the direct supervision of a pharmacist licensed by a state board of pharmacy. CityPlace Pharmacy is able to produce proprietary HealthSpan IV infusion blends to target a variety of wellness needs by replenishing hydration, aiding recovery from illness or stresses, providing hangover relief, restoring vitamin & nutrient levels, refreshing cosmetic appearance and revitalizing a patient’s overall well-being.
Turnkey Capital CEO, Neil Swartz, stated, “In taking HealthSpan Medical Systems public through this intended merger, we are adding the last critical piece to the plan. HealthSpan has the management team, the joint venture agreement with CityPlace for steady product supply, and a signed agreement with MediXall Group, Inc. for sales, promotions and customer service.”
TKCI has also unwound the previously announced agreement with Palm Beach Integrative Medicine, and PBIM owner, Dr. John DeLuca, will not become Chief Medical Officer of HealthSpan.
HealthSpan Medical Systems has a waiting list of physicians who have requested IV Therapy
TKCI low floater, news out
Turnkey Capital Inc. Signs Letter of Intent to Acquire HealthSpan Medical Systems Inc.
Ft. Lauderdale, Florida, May 14, 2018 (GLOBE NEWSWIRE) – Turnkey Capital Inc. (TKCI), today announced it has signed a letter of intent to acquire HealthSpan Medical Systems, Inc., (“Healthspan”) a TBG Holdings company that had previously been operating a medical clinic specializing in IV Therapies, Medical Marijuana registrations and Hormone Replacement therapies (HRT). HealthSpan has recently moved away from the single location clinical model and shifted focus to building IV Therapy Modules for an unlimited number of practitioners to add to their existing clinics, expanding to offer further medical support services within the next few weeks. TKCI will change its name to HealthSpan Medical Systems Inc. and focus its mission, going forward, on creating innovative wellness services that physicians and healthcare practitioners can offer through their clinics to increase revenues and scope of services.
Through a Joint Venture with CityPlace Pharmacy, HealthSpan Medical Systems is building IV Therapy Treatment Modules that can be deployed in a Practitioner’s clinic space to generate revenue for both HealthSpan and the doctor. The Company will also expand the scope to include qualified HealthSpan Physician-supervised Medical Marijuana registration services, as well as personalized Hormone Replacement Therapy. HealthSpan Medical Systems will provide the specialized medical personnel, medical supplies, and equipment to allow any healthcare provider to offer these popular and high-demand treatments.
CityPlace Pharmacy is a licensed Compounding Pharmacy. Pharmaceutical compounding is the customization of legal and FDA-approved substances to conform to individual needs of a human or animal patient, and can only be performed under the direct supervision of a pharmacist licensed by a state board of pharmacy. CityPlace Pharmacy is able to produce proprietary HealthSpan IV infusion blends to target a variety of wellness needs by replenishing hydration, aiding recovery from illness or stresses, providing hangover relief, restoring vitamin & nutrient levels, refreshing cosmetic appearance and revitalizing a patient’s overall well-being.
Turnkey Capital CEO, Neil Swartz, stated, “In taking HealthSpan Medical Systems public through this intended merger, we are adding the last critical piece to the plan. HealthSpan has the management team, the joint venture agreement with CityPlace for steady product supply, and a signed agreement with MediXall Group, Inc. for sales, promotions and customer service.”
TKCI has also unwound the previously announced agreement with Palm Beach Integrative Medicine, and PBIM owner, Dr. John DeLuca, will not become Chief Medical Officer of HealthSpan.
HealthSpan Medical Systems has a waiting list of physicians who have requested IV Therapy
Turnkey Capital Inc. Signs Letter of Intent to Acquire HealthSpan Medical Systems Inc.
Ft. Lauderdale, Florida, May 14, 2018 (GLOBE NEWSWIRE) – Turnkey Capital Inc. (TKCI), today announced it has signed a letter of intent to acquire HealthSpan Medical Systems, Inc., (“Healthspan”) a TBG Holdings company that had previously been operating a medical clinic specializing in IV Therapies, Medical Marijuana registrations and Hormone Replacement therapies (HRT). HealthSpan has recently moved away from the single location clinical model and shifted focus to building IV Therapy Modules for an unlimited number of practitioners to add to their existing clinics, expanding to offer further medical support services within the next few weeks. TKCI will change its name to HealthSpan Medical Systems Inc. and focus its mission, going forward, on creating innovative wellness services that physicians and healthcare practitioners can offer through their clinics to increase revenues and scope of services.
Through a Joint Venture with CityPlace Pharmacy, HealthSpan Medical Systems is building IV Therapy Treatment Modules that can be deployed in a Practitioner’s clinic space to generate revenue for both HealthSpan and the doctor. The Company will also expand the scope to include qualified HealthSpan Physician-supervised Medical Marijuana registration services, as well as personalized Hormone Replacement Therapy. HealthSpan Medical Systems will provide the specialized medical personnel, medical supplies, and equipment to allow any healthcare provider to offer these popular and high-demand treatments.
CityPlace Pharmacy is a licensed Compounding Pharmacy. Pharmaceutical compounding is the customization of legal and FDA-approved substances to conform to individual needs of a human or animal patient, and can only be performed under the direct supervision of a pharmacist licensed by a state board of pharmacy. CityPlace Pharmacy is able to produce proprietary HealthSpan IV infusion blends to target a variety of wellness needs by replenishing hydration, aiding recovery from illness or stresses, providing hangover relief, restoring vitamin & nutrient levels, refreshing cosmetic appearance and revitalizing a patient’s overall well-being.
Turnkey Capital CEO, Neil Swartz, stated, “In taking HealthSpan Medical Systems public through this intended merger, we are adding the last critical piece to the plan. HealthSpan has the management team, the joint venture agreement with CityPlace for steady product supply, and a signed agreement with MediXall Group, Inc. for sales, promotions and customer service.”
TKCI has also unwound the previously announced agreement with Palm Beach Integrative Medicine, and PBIM owner, Dr. John DeLuca, will not become Chief Medical Officer of HealthSpan.
HealthSpan Medical Systems has a waiting list of physicians who have requested IV Therapy
Somebody just stole 45k shares
JFIL .021x .027. Low floater. Good volume and price action the past two days. Watch this bid
JFIL .021x .027. Low floater. Good volume and price action the past two days. Watch this bid